Growth Metrics

Glucotrack (GCTK) Return on Sales (2016 - 2020)

Historic Return on Sales for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to 1379.13%.

  • Glucotrack's Return on Sales fell 14736900.0% to 1379.13% in Q4 2020 from the same period last year, while for Dec 2020 it was 1379.13%, marking a year-over-year decrease of 14058400.0%. This contributed to the annual value of 16.86% for FY2019, which is 1672100.0% up from last year.
  • Glucotrack's Return on Sales amounted to 1379.13% in Q4 2020, which was down 14736900.0% from 59.3% recorded in Q3 2020.
  • Glucotrack's 5-year Return on Sales high stood at 94.56% for Q4 2019, and its period low was 6298.97% during Q2 2020.
  • For the 5-year period, Glucotrack's Return on Sales averaged around 434.62%, with its median value being 12.21% (2016).
  • Within the past 5 years, the most significant YoY rise in Glucotrack's Return on Sales was 2941400bps (2020), while the steepest drop was -62908800bps (2020).
  • Over the past 5 years, Glucotrack's Return on Sales (Quarter) stood at 10.21% in 2016, then skyrocketed by 490bps to 39.85% in 2017, then crashed by -257bps to 62.52% in 2018, then skyrocketed by 251bps to 94.56% in 2019, then tumbled by -1558bps to 1379.13% in 2020.
  • Its Return on Sales stands at 1379.13% for Q4 2020, versus 59.3% for Q3 2020 and 6298.97% for Q2 2020.